Does losartan decrease all-cause mortality more than placebo or first-generation ACE inhibitors for patients with moderate to severe heart failure?

Research output: Contribution to journalArticle

1 Citation (Scopus)
Original languageEnglish (US)
Number of pages1
JournalThe Journal of family practice
Volume49
Issue number5
StatePublished - Jan 1 2000

Fingerprint

Losartan
Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Agents
Meta-Analysis
Heart Failure
Placebos
Mortality

ASJC Scopus subject areas

  • Family Practice

Cite this

@article{6253b2ab96544418aabdca7654664091,
title = "Does losartan decrease all-cause mortality more than placebo or first-generation ACE inhibitors for patients with moderate to severe heart failure?",
author = "LeClair, {Bruce M}",
year = "2000",
month = "1",
day = "1",
language = "English (US)",
volume = "49",
journal = "Journal of Family Practice",
issn = "0094-3509",
publisher = "Appleton-Century-Crofts",
number = "5",

}

TY - JOUR

T1 - Does losartan decrease all-cause mortality more than placebo or first-generation ACE inhibitors for patients with moderate to severe heart failure?

AU - LeClair, Bruce M

PY - 2000/1/1

Y1 - 2000/1/1

UR - http://www.scopus.com/inward/record.url?scp=0034182116&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034182116&partnerID=8YFLogxK

M3 - Article

VL - 49

JO - Journal of Family Practice

JF - Journal of Family Practice

SN - 0094-3509

IS - 5

ER -